Three independent discounted-cash-flow-style models value Medifast, Inc. every trading day. 3 of 3 currently price MED above its market price.
| Free Cash Flow model | $13.94 |
| Excess Profit model | $26.68 |
| Residual Earnings model | $63.12 |
| Dividend Discount model | — |
| Piotroski F-Score | 4 / 9 |
| Return on invested capital | -9.1% |
| Net debt / EBITDA | — |
| Gross margin | +71.3% |
| Revenue CAGR | -37.7% |
| Cash conversion | — |
| Dividend yield | — |
| Buyback yield | -0.5% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open MED in StockKitty